FDA issues recall for ‘Triocef’ antibiotic due to quality defects
MANILA, Philippines — The Food and Drug Administration (FDA) has ordered the recall of several batches of Triocef oral drops (Cefixime), an antibiotic for bacterial infections like pneumonia, bronchitis, and UTI. In FDA Advisory No. 2025-0093 (Feb. 5), The Cathay Drug Company Inc. initiated a voluntary recall after third-party lab tests confirmed the product did not meet required quality standards, “based on the chemical assay tests performed by a third-party laboratory, which also concurred with the results of the manufacturer.” “Based on the submitted test reports, there were inconsistencies in the assay/potency test results,” FDA Director General Dr. Samuel Zacate […]…
Keep on reading: FDA issues recall for ‘Triocef’ antibiotic due to quality defects
Read more